Acorda Therapeutics moved a step closer to collecting the payoff from its $525 million acquisition of Civitas, maker of an inhaled levodopa, in the scramble to…

Oculus Innovative Sciences announced that it has received FDA's 510(k) clearance for its Alevicyn SG Antipruritic Spray Gel to treat dermatologic…

The FDA gave the green light to Johnson & Johnson'sInvega Trinza, which is injected four times an year, making it theongest-acting…

The FDA approved its first combination therapy to treat migraines in pediatric patients, giving its blessings to Pernix Therapeutics' Treximet for use…

The elimination of the Medicare Sustained Growth Rate formula that threatened large Medicare reimbursement cuts to doctors on an annual basis is the most…

Iowa's KemPharm, maker of abuse-resistant versions of painkillers, has set its price range for a possible IPO, seeking up to $56 million at $12 to $14…

To prepare for a wave of opioid candidates in the pipeline, including Pfizer's abuse-deterring, extended-release opioid capsules, the FDA has finalized…

AstraZeneca's Brilinta can now be crushed and mixed with water or deliver through the nose via a tube, the FDA said, in a move designed to help…

Regulatory